OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

NCT02062905 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Allergic Conjunctivitis

Interventions

DRUG: Dexamethasone
OTHER: Placebo Vehicle

Sponsor

Ocular Therapeutix, Inc.

Collaborators

[object Object]